Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR

PHASE3CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Dexmethylphenidate

10, 20, 25-30 mg.

DRUG

Mixed Amphetamine Salts, ER

10, 20, 25-30

DRUG

placebo

randomized placebo week during each 4 week period

Trial Locations (2)

60062

Northbrook HALP Clinic/ADHD Research Center, Northbrook

60608

University of Illinois at Chicago, Chicago

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Seattle Children's Hospital

OTHER

NCT00393042 - Sleep and Tolerability Study: Comparing the Effects of Adderall XR and Focalin XR | Biotech Hunter | Biotech Hunter